Peritoneal Fluid-Derived Small Extracellular Vesicle Proteins as Potential Biomarkers for Endometriosis: A Case-Control Study

H M Nazri, Román Fischer, Joel Steele, Manek S, Sanjiv Manek, K S Subramaniam, Kessler BM, Benedikt M. Kessler, Zondervan Kt, Krina T. Zondervan, Thomas T. Tapmeier, Christian M. Becker, Becker CM
BJOG: An International Journal of Obstetrics & Gynaecology · 2026 · doi:10.1111/1471-0528.70334 · PMID:42786124 · W7214174708
Observational OA: hybrid public-domain-us
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-09-28 ⓘ

Mass spectrometry of peritoneal fluid small extracellular vesicles identified four proteins with significantly different concentrations between endometriosis and control patients, independent of disease stage or cycle phase.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: To demonstrate the presence of peritoneal fluid (PF)-derived small extracellular vesicles (sEVs) in endometriosis and control samples, to characterise their protein content and to define endometriosis-specific biomarkers within the sEV proteome. DESIGN: Case-control experimental study. SETTING: Academic endometriosis centre. SAMPLE: PF samples from women between 18 and 49 years old (n = 63). METHODS: sEVs were enriched using size exclusion chromatography (SEC), and characterised by nanoparticle tracking analysis (NTA), immunoblotting and mass spectrometry, according to surgically-defined disease stage and cycle phase (control, rASRM stages I-II and III-IV endometriosis, in proliferative, secretory, and menstrual phases). FragPipe was used for protein identification. MAIN OUTCOME MEASURES: Protein content of sEVs from control and endometriosis PF samples. RESULTS: sEVs were identified in PF of women by NTA, immunoblotting and mass spectrometry. Four proteins were significantly different across all samples: fructose-bisphosphate aldolase A (ALDOA: 3.12-fold increase in control samples, p = 0.0164), heat shock protein 90-alpha (HSP90AA1: 2.14-fold increase in control samples, p = 0.0245), collagen alpha-1 (XV) chain (COL15A1: 1.83-fold increase in control samples, p = 0.0421), and protein S100-A10 (2.54-fold increase in endometriosis samples, p = 0.0421). CONCLUSIONS: PF-derived sEVs differ between endometriosis and control patients. Concentrations vary regardless of cycle phase and disease stage, and this difference appears to be reflected in the proteomics analysis. However, higher sampling numbers are needed to confirm findings and functional assays to be performed delineate sEV function in endometriosis pathophysiology. Correlating PF-derived sEV proteins with those in blood or urine could help further understand endometriosis and lead to the identification of biomarkers for diagnosis.

My notes (saved in your browser only)

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (45)

Source provenance

europepmc
last seen: 2026-10-19T06:17:24.038039+00:00
openalex
last seen: 2026-10-19T06:08:44.544802+00:00
pubmed
last seen: 2026-10-19T06:10:22.293094+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine